This article presents an example of how clinical trial data may be complemented by real-world evidence by reviewing pivotal clinical trial data for one direct oral anticoagulant (DOAC), along with an ...
Optimising RSV sample handling and laboratory workflows to support faster, more efficient clinical trial delivery.
Many oral drugs show a high variability in pharmacokinetic exposure, and, for drugs with exposure related to efficacy, therapeutic drug monitoring can help optimize exposure in individual patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback